Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

282

Participants

Timeline

Start Date

December 7, 2020

Primary Completion Date

October 31, 2022

Study Completion Date

April 28, 2023

Conditions
Painful Diabetic Peripheral Neuropathy
Interventions
DRUG

ricolinostat

120 mg per dose in 12 mL liquid formulation

DRUG

Placebo

12 mL liquid formulation placebo

Trial Locations (35)

11235

NY Scientific, Brooklyn

27103

The Center for Clinical Research, Winston-Salem

27410

Triad Clinical Trials, Greensboro

29405

Coastal Carolina Research Center, North Charleston

29485

Palmetto Clinical Research, Summerville

30046

Physicians Research Associates, LLC, Lawrenceville

32127

Progressive Medical Research, Port Orange

32746

DeLand Clinical Research Unit, Lake Mary

32751

ClinCloud LLC, Maitland

33134

APF Research LLC, Miami

33183

International Research Associates LLC, Miami

33401

Metabolic Research Institute Inc, West Palm Beach

33634

Meridien Research, Tampa

33756

Innovative Research of West Florida Inc, Clearwater

34761

Sensible Healthcare LLC, Ocoee

36207

Pinnacle Research Group LLC, Anniston

38654

Olive Branch Family Medical Center, Olive Branch

47714

MediSphere Medical Research Center, LLC, Evansville

70072

Tandem Clinical Research, Marrero

77030

Nerve and Muscle Center of Texas, Houston

78215

Sun Research Institute, San Antonio

78229

Diabetes & Glandular Disease Clinic, P.A., San Antonio

78731

FutureSearch Trials of Neurology, Austin

83404

Rocky Mountain Clinical Research, Idaho Falls

84107

Wasatch Clinical Research LLC, Salt Lake City

85053

Arizona Research Center, Phoenix

89123

Advanced Biomedical Research of America, Las Vegas

90255

National Research Institute, Huntington Park

90717

Torrance Clinical Research Institute Inc, Lomita

91606

Providence Clinical Research, North Hollywood

92037

Altman Clinical and Translational Research Institute, La Jolla

92648

Diabetes/Lipid Management & Research Center, Huntington Beach

94115

Center for Clinical Research Inc, San Francisco

94598

Diablo Clinical Research Inc, Walnut Creek

08009

Hassman Research Institute, Berlin

All Listed Sponsors
lead

Regenacy Pharmaceuticals LLC

INDUSTRY

NCT03176472 - Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy | Biotech Hunter | Biotech Hunter